On September 29, 2026, BlackRock, Inc. disposed of 2.62 million H-shares of HENGRUI PHARMA off-exchange, by way of ceasing to hold a security interest in shares (non-cash assets), not a direct secondary-market dealing.
Prior to the disposal, BlackRock, Inc.'s long position in HENGRUI PHARMA was 18.00 million shares, representing 6.97%; following the disposal, the holding changed to 15.38 million shares, with the long position ratio falling to 5.96%.